Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Combination Chemotherapy
100%
Intranasal
100%
Murine Lewis Lung Carcinoma
100%
Humoral Factors
100%
Carcinoma Metastasis
100%
Lung
40%
Lymphoid Cells
40%
Lung Metastasis
40%
Cancer Chemotherapy
40%
Immunomodulatory
20%
Drug-induced
20%
Chemotherapy
20%
Infiltration
20%
Tumor
20%
Therapeutic Modalities
20%
Octapeptide
20%
Syngeneic
20%
Treatment Modalities
20%
Lewis Lung Carcinoma
20%
C57BL
20%
Experimental Animal Models
20%
Plasmacytoma
20%
Survival Time
20%
Cellular Compartments
20%
Antimetastatic
20%
Footpad
20%
Induced Defects
20%
Prolonged Survival
20%
Lung Carcinoma
20%
Immune Parameters
20%
Safe Treatment
20%
Combination Immunotherapy
20%
Lung Weight
20%
Melphalan
20%
Chemotherapy Alone
20%
Tumor Emboli
20%
Medicine and Dentistry
Metastatic Carcinoma
100%
Lewis Lung Carcinoma
100%
Immunotherapy
100%
Prothrombin
100%
Humoral Thymus Factor
100%
Chemotherapy
100%
Lung
60%
Lung Metastasis
40%
Lymphoid Cell
40%
Immunocompetence
40%
Cancer Chemotherapy
40%
Therapeutic Modality
20%
Neoplasm
20%
Target Tissue
20%
C57BL/6
20%
Single Drug Dose
20%
Survival Time
20%
Tumor
20%
Lung Carcinoma
20%
Chemoimmunotherapy
20%
Octapeptide
20%
Cell Compartment
20%
Melphalan
20%
Plasmacytoma
20%
Treatment Modality
20%
Embolism
20%
Pharmacology, Toxicology and Pharmaceutical Science
Lewis Carcinoma
100%
Immunotherapy
100%
Prothrombin
100%
Chemotherapy Regimens
100%
Humoral Thymus Factor
100%
Lung Metastasis
40%
Neoplasm
20%
C57BL 6 Mouse
20%
Experimental Animal
20%
Survival Time
20%
Lung Carcinoma
20%
Octapeptide
20%
Melphalan
20%
Plasmacytoma
20%
Embolism
20%
Immunology and Microbiology
Immunotherapy
100%
Humoral Thymus Factor
100%
Lung
100%
Immunocompetence
28%
Innate Lymphoid Cell
28%
Plasmacytoma
14%
Syngenic
14%
C57BL 6 Mouse
14%
Survival Time
14%
Target Tissue
14%
Normal Value
14%
Experimental Animal
14%
Lung Weight
14%